The interaction of norepinephrine and prostaglandin E1 on the adenyl cyclase system of human and rabbit blood platelets.
D000225:Adenine / Q000378:metabolism; D000227:Adenine Nucleotides; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D000242:Cyclic AMP / Q000096:biosynthesis; D004798:Enzymes / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D010770:Phosphotransferases / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000494:pharmacology*; D011817:Rabbits; D013268:Stimulation, Chemical; D014316:Tritium
D000227:Adenine Nucleotides; D000067956:Adenylyl Cyclase Inhibitors; D004798:Enzymes; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D014316:Tritium; D011433:Propranolol; D000242:Cyclic AMP; D010770:Phosphotransferases; D000262:Adenylyl Cyclases; D000225:Adenine; D009638:Norepinephrine; D010646:Phentolamine